SNOA: Sonoma Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SNOA: Sonoma Pharmaceuticals, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 6.37
Enterprise Value ($M) 1.21
Book Value ($M) 4.87
Book Value / Share 3.01
Price / Book 1.31
NCAV ($M) 3.58
NCAV / Share 2.22
Price / NCAV 1.78

Profitability (mra)
Return on Invested Capital (ROIC) -0.74
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.56

Liquidity (mrq)
Quick Ratio 2.49
Current Ratio 3.34

Balance Sheet (mrq) ($M)
Current Assets 12.38
Assets 13.67
Liabilities 8.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT T
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SEC
2024-06-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 17,406 103,876 16.76
2025-04-28 96,370 328,836 29.31
2025-04-25 188,582 1,131,972 16.66
2025-04-24 190,879 867,441 22.00

(click for more detail)

Similar Companies
SLNO – Soleno Therapeutics, Inc. SMLR – Semler Scientific, Inc.
SMTI – Sanara MedTech Inc. SRTS – Sensus Healthcare, Inc.
SSII – SS Innovations International, Inc.


Financial data and stock pages provided by
Fintel.io